Exchange: NASDAQ·Updated 02:54 AM EDT
ABCL logo

ABCL AbCellera Biologics Inc

$11.26
$0.02
(0.18%)
Overnight
Prev Close $11.28
Reported EarningsAug 5
Mkt Cap$3.72B
Vol4.25M

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
31

Bearish Sentiment

How do you feel about ABCL?

Advertisement|Remove ads.